| Application no. and date | 08836256.1 (espacenet) (Federated) (European Patent Register), 20081003 | | Patent/reg. no. and date | DK/EP 2214666, 20131211 | | Publication date | 20100811 | | Priority no. and date | US 977953 P, 20071005, US 46109, 20080418 | | EP pub. no. and date |
EP 2214666 20100811 | | Effective date | | | Applicant/owner | Alzheimer's Institute of America, Inc., 7837 Parallel Parkway
Kansas City, KS 66112, US | | Applicant ref. no. | P81314336DK00E | | Inventor | PARIS, Daniel, 2040 Whitfield Avenue
Sarasota
Florida 34243, US,
MULLAN, Michael, J., 2040 Whitfield Avenue
Sarasota
Florida 34243, US,
IVEY, Robert, A., III, 2040 Whitfield Avenue
Sarasota
Florida 32243, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4422 (2006.01) , A61P 25/28 (2006.01) | | Title | FREMGANGSMÅDE TIL REDUCERING AF AMYLOID-AFSÆTNING, AMYLOID-NEUROTOKSICITET OG MIKROGLIOSE MED (-)-NILVADIPIN-ENANTIOMER | | Int. application no. | US2008078786 | | Int. publication no. | WO2009046323 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
